Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1980 Jan;68(1):8–10. doi: 10.1111/j.1476-5381.1980.tb10689.x

Effect of propranolol on beta-adrenoceptors in rat hearts.

S P Baker, L T Potter
PMCID: PMC2044089  PMID: 6244034

Abstract

The question of whether the chronic administration of propranolol modifies the numbers or properties of cardiac beta-adrenoceptors was examined because of many reports suggestive of cardiac hypersensitivity following the withdrawal of beta-antagonists. In three studies, rats were given (+/-)-propranolol, 30 mg/day, orally or intraperitoneally, for 1 to 7 weeks. The numbers and affinities of specific binding sites for radioactive dihydroalprenolol in whole hearts from 60 control and 75 test animals were found to be the same. Thus catecholamine deprivation does not exert an important regulatory effect on most beta-receptors in the heart, as it does in the brain.

Full text

PDF
8

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker S. P., Boyd H. M., Potter L. T. Distribution and function of beta-adrenoceptors in different chambers of the canine heart. Br J Pharmacol. 1980 Jan;68(1):57–63. doi: 10.1111/j.1476-5381.1980.tb10698.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baker S. P., Potter L. T. Cardiac beta-adrenoceptors during normal growth of male and female rats. Br J Pharmacol. 1980 Jan;68(1):65–70. doi: 10.1111/j.1476-5381.1980.tb10699.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boudoulas H., Lewis R. P., Kates R. E., Dalamangas G. Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann Intern Med. 1977 Oct;87(4):433–436. doi: 10.7326/0003-4819-87-4-433. [DOI] [PubMed] [Google Scholar]
  4. Faulkner S. L., Hopkins J. T., Boerth R. C., Young J. L., Jr, Jellett L. V., Nies A. S., Bender H. W., Shand D. G. Time required for complete recovery from chronic propranolol therapy. N Engl J Med. 1973 Sep 20;289(12):607–609. doi: 10.1056/NEJM197309202891204. [DOI] [PubMed] [Google Scholar]
  5. Glaubiger G., Lefkowitz R. J. Elevated beta-adrenergic receptor number after chronic propranolol treatment. Biochem Biophys Res Commun. 1977 Sep 23;78(2):720–725. doi: 10.1016/0006-291x(77)90238-8. [DOI] [PubMed] [Google Scholar]
  6. Lemmer B., Saller R. Influence of light and darkness on the turnover of noradrenaline in the rat heart. Naunyn Schmiedebergs Arch Pharmacol. 1974;282(1):75–84. doi: 10.1007/BF00647404. [DOI] [PubMed] [Google Scholar]
  7. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  8. Molinoff P. B., Sporn J. R., Wolfe B. B., Harden T. K. Regulation of beta-adrenergic receptors in the cerebral cortex. Adv Cyclic Nucleotide Res. 1978;9:465–483. [PubMed] [Google Scholar]
  9. Myers J. H., Horwitz L. D. Hemodynamic and metabolic response after abrupt uithdrawal of long-term propranolol. Circulation. 1978 Aug;58(2):196–201. doi: 10.1161/01.cir.58.2.196. [DOI] [PubMed] [Google Scholar]
  10. Shand D. G., Wood A. J. Propranolol withdrawal syndrome - why? Circulation. 1978 Aug;58(2):202–203. doi: 10.1161/01.cir.58.2.202. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES